Literature DB >> 18228464

Analysis of cellular senescence in culture in vivo: the senescence-associated beta-galactosidase assay.

Debdutta Bandyopadhyay1, Catherine Gatza1, Lawrence A Donehower1, Estela E Medrano1.   

Abstract

Replicative senescence, a process first described almost 40 years ago, entails irreversible growth arrest with sustained metabolic functions, and it is also associated with increased resistance to apoptotic signals. Interest in this process has increased greatly over the last 10 years, as it has been demonstrated that senescence can function as a potent tumor suppressor mechanism. Although mounting evidence suggests that the senescent phenotype is associated with an extraordinarily complex array of gene expression patterns and interactions with the microenvironment, there is only one widely accepted marker for distinguishing such cells in vitro and in vivo. This marker is the senescence-associated expression of a pH 6 beta-galactosidase (SA-beta-gal). Here, a method for analyzing SA-beta-gal expression in cultured cells and in human and animal tissues is described, and important parameters to consider when performing such assays are also highlighted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 18228464     DOI: 10.1002/0471143030.cb1809s27

Source DB:  PubMed          Journal:  Curr Protoc Cell Biol        ISSN: 1934-2616


  10 in total

1.  MYC-driven tumorigenesis is inhibited by WRN syndrome gene deficiency.

Authors:  Russell Moser; Masafumi Toyoshima; Kristin Robinson; Kay E Gurley; Heather L Howie; Jerry Davison; Martin Morgan; Christopher J Kemp; Carla Grandori
Journal:  Mol Cancer Res       Date:  2012-02-01       Impact factor: 5.852

2.  A p53/ARF-dependent anticancer barrier activates senescence and blocks tumorigenesis without impacting apoptosis.

Authors:  Vidya C Sinha; Lan Qin; Yi Li
Journal:  Mol Cancer Res       Date:  2014-09-24       Impact factor: 5.852

3.  p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation.

Authors:  Tamara Terzian; Enrique C Torchia; Daisy Dai; Steven E Robinson; Kazutoshi Murao; Regan A Stiegmann; Victoria Gonzalez; Glen M Boyle; Marianne B Powell; Pamela M Pollock; Guillermina Lozano; William A Robinson; Dennis R Roop; Neil F Box
Journal:  Pigment Cell Melanoma Res       Date:  2010-12       Impact factor: 4.693

4.  Novel S-Gal(®) analogs as (1)H MRI reporters for in vivo detection of β-galactosidase.

Authors:  Praveen K Gulaka; Jian-Xin Yu; Li Liu; Ralph P Mason; Vikram D Kodibagkar
Journal:  Magn Reson Imaging       Date:  2013-04-18       Impact factor: 2.546

5.  Withaferin a alters intermediate filament organization, cell shape and behavior.

Authors:  Boris Grin; Saleemulla Mahammad; Tatjana Wedig; Megan M Cleland; Lester Tsai; Harald Herrmann; Robert D Goldman
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

6.  Inhibition of IGF-1R prevents ionizing radiation-induced primary endothelial cell senescence.

Authors:  Ronald Allan M Panganiban; Regina M Day
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

7.  A long non-coding RNA is required for targeting centromeric protein A to the human centromere.

Authors:  Delphine Quénet; Yamini Dalal
Journal:  Elife       Date:  2014-08-12       Impact factor: 8.140

8.  Telomere Transcripts Target Telomerase in Human Cancer Cells.

Authors:  Theresa Kreilmeier; Doris Mejri; Marlene Hauck; Miriam Kleiter; Klaus Holzmann
Journal:  Genes (Basel)       Date:  2016-08-16       Impact factor: 4.096

9.  A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS.

Authors:  Mary McMahon; Adrian Contreras; Mikael Holm; Tamayo Uechi; Craig M Forester; Xiaming Pang; Cody Jackson; Meredith E Calvert; Bin Chen; David A Quigley; John M Luk; R Kate Kelley; John D Gordan; Ryan M Gill; Scott C Blanchard; Davide Ruggero
Journal:  Elife       Date:  2019-09-03       Impact factor: 8.140

10.  Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma.

Authors:  Helty Adisetiyo; Mengmeng Liang; Chun-Peng Liao; Ari Aycock-Williams; Michael B Cohen; Shili Xu; Nouri Neamati; Edward M Conway; Chieh-Yang Cheng; Alexander Yu Nikitin; Pradip Roy-Burman
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.